The Board of Directors of Astral Limited has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The approval was granted following recommendations from the Audit Committee during a board meeting held on August 12, 2026.

Financial Disclosure Details

The company confirmed that the detailed financial results, along with the reports of the statutory auditors, are accessible to investors. These documents are hosted on the company’s official website and the respective stock exchange platforms.

Key Information

• Approval Date: August 12, 2026
• Quarter Ended: June 30, 2026
• Result Type: Unaudited Standalone and Consolidated
• Auditor Status: Reports issued by statutory auditors

Investors can access the full format of the quarterly results via the company’s investor relations section or by scanning the Quick Response Code provided in the original filing. The disclosure complies with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Astral Limited reported a consolidated net profit of ₹1.2b for Q1FY27, up from ₹811m in the year-ago period, beating the analyst estimate of ₹1.16b. Consolidated revenue from operations rose to ₹15.78b from ₹13.6b YoY, slightly missing the estimate of ₹15.88b. EBITDA came in at ₹2.34b versus ₹1.85b YoY, ahead of the ₹2.31b estimate, with EBITDA margin expanding to 14.81% from 13.58% YoY, also beating the estimate of 14.58%. Management reported a 15.9% growth in Q1FY27 with a 15.5% EBITDA margin and expressed confidence in surpassing the annual growth guidance of 20-25%.

The Board of Directors approved the unaudited standalone and consolidated financial results on August 12, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the Statutory Auditors, S R B C & Co LLP. Standalone net profit stood at ₹1,358 million, up 40.6% from ₹966 million in Q1FY26, with standalone revenue rising 13.3% to ₹13,678 million.

Segment performance

The Plumbing segment remained the primary growth engine, with revenue increasing 10.1% YoY to ₹10,505 million. Despite industry demand falling approximately 10% due to polymer price volatility, Astral gained market share, achieving flat volume growth of 0.1% (56,146 M.T.) but higher value realizations. Segment EBITDA rose 26.7% to ₹1,983 million, with margins expanding to 18.9% from 16.4% in Q1FY26, the highest among industry players. The Plumbing division continues with double-digit volume growth and maintains an EBITDA margin guidance of 16-18%.

The Paints and Adhesives segment posted revenue growth of 29.5% to ₹5,275 million, driven by a 48.7% rise in Paints sales and 24.9% growth in Adhesives. Segment EBITDA rose 21.9% to ₹457 million, though margins contracted slightly to 8.7% from 9.2% due to raw material cost pressures. For the full year, the Adhesive India business aims for 15-20% growth and a 15% EBITDA margin, while Adhesive UK seeks double-digit growth (Q1 was 26%) with an 8-10% EBITDA margin. The Paint segment projects 20-25% revenue growth but lower single-digit EBITDA margin, and Bathware expects a 20-25% CAGR over the next 4-5 years.

Key financial metrics

The following table summarises Astral's Q1FY27 consolidated performance against year-ago figures and analyst estimates.

Strategic developments

Astral expanded its Pipes and Fittings production capacity from 417,645 M.T. to 421,497 M.T. during the quarter. The new CPVC Resin plant (Phase I, 40,000 M.T.) is set for completion by late December, with trial runs planned for Q4. PEX-Aluminum-PEX machines are scheduled to start production by September end. The FY27 capex budget is estimated at INR 300-350 crore. This vertical integration is expected to improve margins and gain market share in CPVC pipes and fittings.

In the Adhesives business, New Bharat accelerated rural expansion, adding over 8,000 towns and taking direct dealers beyond 1,500. The International Adhesive Business grew 26% YoY, delivering an EBITDA margin of 4.9%. Additionally, Astral Chemie Limited acquired a 60% stake in Differentiated & Sustainable Solutions LLP (DSS) for an upfront payment of ₹391 million. DSS contributed ₹67 million in sales and ₹9 million in EBITDA in its first quarter, expanding Astral's portfolio into Specialty Chemicals.

What the numbers show

Astral's Q1FY27 results reflect strong operational leverage, with EBITDA growing faster than revenue. The company beat analyst estimates for both EBITDA (₹2.34b vs ₹2.31b estimated) and net profit (₹1.2b vs ₹1.16b estimated), indicating better-than-expected cost management or pricing power. The divergence between flat volume growth in Plumbing and double-digit revenue growth highlights successful price realization strategies amidst volatile polymer costs. EBITDA margin expansion to 14.81% from 13.58% in Q1FY26 points to improved operational efficiency across segments. Management’s confidence in surpassing the 20-25% annual growth guidance is underpinned by the Plumbing division’s continued double-digit volume growth and robust margin targets.